Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Fisher

Showing results (71-80 of 498) with videos related to

Pageof 50
Sort By:
Cancer Research|March 1, 1981
Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancerC P Vanhaelen, R I Fisher
Personality & Social Psychology Bulletin|November 11, 2018
Personal Ties and Prejudice: A Meta-Analysis of Romantic Attachment and Ambivalent SexismMolly I Fisher, Matthew D Hammond
Canadian Medical Association Journal|August 12, 1978
The staging and treatment of epithelial ovarian cancerR C Young, R I Fisher
Seminars in Oncology|October 1, 1991
Clinical trials of alpha-interferon in the treatment of non-Hodgkin's lymphomaE R Gaynor, R I Fisher
Oncology (Williston Park, N.Y.)|December 1, 1995
Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?E R Gaynor, R I Fisher
Expert Review of Anticancer Therapy|January 30, 2004
Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphomaJonathan W Friedberg, Richard I Fisher
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1981
Increased sensitivity of lymphocytes from patients with Hodgkin's disease to concanavalin A-induced suppressor cellsC P Vanhaelen, R I Fisher
Disease-A-Month : DM|September 1, 1989
Recent advances in the management of non-Hodgkin's lymphomasE R Gaynor, R I Fisher
Journal of Biomolecular Screening|November 21, 2015
Development of a Medium-Throughput Targeted LCMS Assay to Detect Endogenous Cellular Levels of Malonyl-CoA to Screen Fatty Acid Synthase InhibitorsPhilip J Hopcroft, David I Fisher
Oncogene|August 24, 2004
The epidemiology of non-Hodgkin's lymphomaSusan G Fisher, Richard I Fisher
Pageof 50

Showing results (71-80 of 498) with videos related to

Sort By:
Pageof 50
Cancer Research|March 1, 1981
Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancerC P Vanhaelen, R I Fisher
Personality & Social Psychology Bulletin|November 11, 2018
Personal Ties and Prejudice: A Meta-Analysis of Romantic Attachment and Ambivalent SexismMolly I Fisher, Matthew D Hammond
Canadian Medical Association Journal|August 12, 1978
The staging and treatment of epithelial ovarian cancerR C Young, R I Fisher
Seminars in Oncology|October 1, 1991
Clinical trials of alpha-interferon in the treatment of non-Hodgkin's lymphomaE R Gaynor, R I Fisher
Oncology (Williston Park, N.Y.)|December 1, 1995
Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?E R Gaynor, R I Fisher
Expert Review of Anticancer Therapy|January 30, 2004
Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphomaJonathan W Friedberg, Richard I Fisher
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1981
Increased sensitivity of lymphocytes from patients with Hodgkin's disease to concanavalin A-induced suppressor cellsC P Vanhaelen, R I Fisher
Disease-A-Month : DM|September 1, 1989
Recent advances in the management of non-Hodgkin's lymphomasE R Gaynor, R I Fisher
Journal of Biomolecular Screening|November 21, 2015
Development of a Medium-Throughput Targeted LCMS Assay to Detect Endogenous Cellular Levels of Malonyl-CoA to Screen Fatty Acid Synthase InhibitorsPhilip J Hopcroft, David I Fisher
Oncogene|August 24, 2004
The epidemiology of non-Hodgkin's lymphomaSusan G Fisher, Richard I Fisher
Pageof 50